NCT04686747View on ClinicalTrials.gov

COVID - 19 and Advanced Gastro-intestinal Cancer Treatment

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

March 1, 2021

Study Completion Date

June 30, 2021

Conditions
Pancreatic CancerGastric CancerEsophagus CancerColorectal Cancer
Trial Locations (1)

58100

Department of General and Emergency Surgery. Misericordia Hospital. Director: Coratti Andrea, MD, Grosseto

All Listed Sponsors
lead

S.M. Misericordia Hospital

OTHER

NCT04686747 - COVID - 19 and Advanced Gastro-intestinal Cancer Treatment | Biotech Hunter | Biotech Hunter